0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
eClinical Solutions Market by Product (CDMS, EDC, CTMS, RTMS, Clinical Data Integration Platform, eCOA, Safety Solutions, eTMF, RIMS, and Others), Clinical Trial (Phase I, PhaseII, Phase III, Phase IV), Delivery Mode (Web-hosted, Licensed Enterprise, and Cloud-based), Geography (Asia Pacific, Europe, North America and Rest of the World)- Forecast to 2026
Published Date: June 2021
|
Report Code: INFO-Othe-2O60
Home | Market Reports | Health | Medical Facilities & Services | Hospitals & Treatment Centers
eClinical Solutions Market

eClinical Solutions Market by Product (CDMS, EDC, CTMS, RTMS, Clinical Data Integration Platform, eCOA, Safety Solutions, eTMF, RIMS, and Others), Clinical Trial (Phase I, PhaseII, Phase III, Phase IV), Delivery Mode (Web-hosted, Licensed Enterprise, and Cloud-based), Geography (Asia Pacific, Europe, North America and Rest of the World)- Forecast to 2026

Code: INFO-Othe-2O60
Report
June 2021
92 Pages
Infoholic Research
Region:
Description
Table of Content
Tables & Figures

eClinical Solutions Market Statistics 2026

Globally, the eClinical Solutions Market is growing at a CAGR of 12.5% during the forecast period of 2020-2026, with a base value of USD 6.27 Billion in 2020 to USD 12.76 Billion in 2026. Major factors that are characterizing the market growth are increasing R&D activities by biopharmaceutical and pharmaceutical companies.

eclinical solutions market

What is eClinical Solutions?

eClinical solutions are the ones that combine clinical technology with expertise and are widely used to improve the clinical development process through various data tools such as data management and data analysis.

eClinical Solutions market size

eClinical Solutions Market Trends

Rising burden of chronic diseases, soaring expenditure on the development of clinical trials, and increased adoption of smart devices for healthcare service management. The reasons for the high demand for eClinical solutions are the rising costs of operational and regulatory requirements.

eClinical Solutions Market Segmentation

The eClinical solutions market is segregated on the basis of product, clinical trial, delivery mode, and by geography:

By Product

Based on the product, the market segmented by EDC and CDMS, CTMS, Clinical Analytics Platform, RTMS, Clinical Data Integration Platform, eCOA, Safety Solutions, eTMF, RIMS, others. Electronic Clinical Outcome Assessment (eCOA) is assumed to be the rapidly growing segment in the forecast period 2020-2026 since the growing importance of high-quality clinical data. The process of data capturing using eCOA platforms improve the quality of information captured, efficient data collection procedures as well as offers potential data analysis.

By Clinical Trail

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Based on the clinical trial phase, the market of EClinical is segmented into Phase I, Phase II, Phase III, and Phase IV. The phase III clinical trial segment is likely to lead the market throughout the forecast period. The need for integration of clinical data management software to restrain overall cost and improve process efficiency as well as an increasing number of drugs successfully reaching phase III is impelling the growth of the segment. Phase III involves the study of the efficacy of a drug by using a group of more than 1,000 patients. A large number of patients increase the complication of the study, which prompts the demand for computer-based systems, thereby rev up the acquisition.

By Delivery Mode

  • Web-Hosted
  • Licensed Enterprise
  • Cloud-Based

Based on delivery mode, the market has been segmented into three categories: Web-hosted (On-demand), Licensed Enterprise (On-premise), and Cloud-based. Web-hosted solutions have been the dominating segment in the market for eClinical solutions in 2019. The benefits of this segment, such as easy accessibility, usability, and lower investments required, are attributed to the dominance of this segment. Web-hosted products are versatile as they are easily customizable, owing to this fact, providers can also customize the presentation details of information for different user groups. Moreover, these products possess a greater level of interoperability. The segment is predicted to be maintaining its position throughout the forecast period of 2020-2026.

Further, in the end-user segmentation, the market is segmented among the contract research organizations, pharmaceutical, and biopharmaceutical companies, medical device manufacturers, consulting service companies, hospitals, and academic research institutions. The contract research organization is having the highest lucrative share in the market. The segment is expected to enlarge at a distinctive CAGR in the forecast period ascribed to the rising tendency of pharmaceutical companies to decline overall spending. There has been a growth in the adoption of eClinical solutions in R&D, which is further broadening the scope of the segment.

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

For the year 2019, North America was the leading revenue contributor. The target population, which is constantly increasing, is coming with a risk of lifestyle-associated diseases such as cardiac disorders and diabetes. This is expected to lead to growth in the regional market for EClinical Solutions. Even the presence of significant companies, as well as the attainability of fully-developed infrastructure, is expected to accelerate the growth of the market of eClinical solutions.

Asia Pacific is projected to record a notable CAGR over the 2020-2026 forecast periods. High unfulfilled medical requirements and the increasing incidence of non-communicable diseases such as cancer, cardiovascular, and infectious diseases are stoking the demand for eClinical solutions in the region.

The factors which are responsible for driving this market are increasing acquisition of eClinical solutions for advanced data arrangement process as well as the acquisition of novel software solutions, which helps in organizing the research activities in clinical research.

Key Companies

  • Crf Health,
  • Oracle Corporation,
  • Medidata Solutions, Inc,
  • Bioclinica, Inc,
  • Parexel International Corporation,
  • Thermo Fisher Scientific, Inc,
  • Merge Healthcare Incorporated,
  • Omnicomm Systems Inc,
  • ERT CLINICAL,
  • Maxisit Inc.

This market report will help the market players to comprehend various key market trends, market dynamics, and the needs of the end-users. The qualitative and quantitative analysis of the market definitely enables the user experience of the report.

  • Overall information is given by the major competitors on eClinical solutions in this report.
  • This research offers present technologies, research activities in the eClinical solutions market.
  • Analysis based on the quantitative of the market assists the users to know the actual facts of the market across four major regions, and then accordingly, the company may plan to enter into any region.

Scope of eClinical Solutions Market

 

Report Metric

Details

Report Name

eClinical Solutions Market

The market size in 2020

USD 6.27 Billion

The revenue forecast in 2026

USD 12.76 Billion

Growth Rate

CAGR of 12.5%

By Product

CDMS, EDC, CTMS, RTMS, Clinical Data Integration Platform, eCOA, Safety Solutions, eTMF, RIMS

By Delivery Mode

Web-hosted, Licensed Enterprise, and Cloud-based

Key Companies

Crf Health, Oracle Corporation, Medidata Solutions, Inc, Bioclinica, Inc, Parexel International Corporation, Thermo Fisher Scientific, Inc, Merge Healthcare Incorporated, Omnicomm Systems Inc, ERT CLINICAL, Maxisit Inc.

Frequently Asked Questions About This Report

1. How big is the eClinical Solutions market?

Ans. Globally, the eClinical Solutions Market is growing at a CAGR of 12.5% during the forecast period of 2020-2026, with a base value of USD 6.27 Billion in 2020 to USD 12.76 Billion in 2026.

2. Who are the key companies available in the eClinical solutions Industry?

Ans. Some of the major companies are CRF Health, ORACLE CORPORATION, Medidata Solutions, Inc., Bioclinica, PAREXEL International Corporation, Thermo Fisher Scientific Inc, Merge Healthcare Incorporated, ERT Clinical, Maxisit.

3. Which region holds largest market share in the eClinical solutions market?

Ans. Asia Pacific is projected to record a notable CAGR over the 2020-2026 forecast periods. High unfulfilled medical requirements and the increasing incidence of non-communicable diseases such as cancer, cardiovascular, and infectious diseases are stoking the demand for eClinical solutions in the region.

4. Which is the largest segmentation in the eClinical solutions?

Ans. Electronic Clinical Outcome Assessment (eCOA) is assumed to be the rapidly growing segment in the forecast period 2020-2026 since the growing importance of high-quality clinical data. The process of data capturing using eCOA platforms improve the quality of information captured, efficient data collection procedures as well as offers potential data analysis.

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.3. PEST Analysis

3.4. Porter Five Forces

3.5. Related Markets

4. Market characteristics

4.1. Market Evolution

4.2. Market Trends and Impact

4.3. Advantages/Disadvantages of Market

4.4. Regulatory Impact

4.5. Market Offerings

4.6. Market Segmentation

4.7. Market Dynamics

4.7.1. Drivers

4.7.2. Restraints

4.7.3. Opportunities

4.8. DRO - Impact Analysis

5. Product: Market Size & Analysis

5.1. Overview     

5.2. Electronic Data Capture and Clinical Data Management Systems 

5.3. Clinical Trial Management Systems

5.4. Clinical Analytics Platform

5.5. Randomization and Trial Supply Management

5.6. Electronic Trail Master Files

5.7. Electronic Clinical Outcome Assessment

5.8. Safety Solutions 

5.9. Electronic Trail Master Files

5.10. Regulatory Information Management Solutions

5.11. Others         

6. Delivery Mode: Market Size & Analysis

6.1. Overview

6.2. Web-hosted

6.3. Licensed Enterprise 

6.4. Cloud-based                        

7. End User: Market Size & Analysis

7.1. Overview

7.2. Pharmaceutical and Biopharmaceutical Companies

7.3. Next-generation Sequencing

7.4. Polymerase Chain Reaction

7.5. Medical Device Manufacturers 

7.6. Hospitals

7.7. Academic Research Institutions        

8. Clinical Trial Phase: Market Size & Analysis

8.1. Overview

8.2. Phase I 

8.3. Phase II

8.4. Phase III

8.5. Phase IV      

9. Geography: Market Size & Analysis

9.1. Overview

9.2. North America

9.3. Europe

9.4. Asia Pacific

9.5. Rest of the World

10. Competitive Landscape

10.1. Competitor Comparison Analysis

10.2. Market Developments

10.3. Mergers and Acquisitions, Legal, Awards, Partnerships

10.4. Product Launches and execution

11. Vendor Profiles

11.1. Oracle Corporation

11.1.1. Overview

11.1.2. Product Offerings

11.1.3. Geographic Revenue

11.1.4. Business Units

11.1.5. Developments

11.1.6. Business Strategy

11.2. Medidata Solutions, Inc

11.2.1. Overview

11.2.2. Product Offerings

11.2.3. Geographic Revenue

11.2.4. Business Units

11.2.5. Developments

11.2.6. Business Strategy

11.3. Parexel International Corporation

11.3.1. Overview

11.3.2. Product Offerings

11.3.3. Geographic Revenue

11.3.4. Business Units

11.3.5. Developments

11.3.6. Business Strategy

11.4. Bioclinica, Inc.

11.4.1. Overview

11.4.2. Product Offerings

11.4.3. Geographic Revenue

11.4.4. Business Units

11.4.5. Developments

11.4.6. Business Strategy

11.5. Thermo Fisher Scientific, Inc

11.5.1. Overview

11.5.2. Product Offerings

11.5.3. Geographic Revenue

11.5.4. Business Units

11.5.5. Developments

11.5.6. Business Strategy

11.6. Crf Health.

11.6.1. Overview

11.6.2. Product Offerings

11.6.3. Geographic Revenue

11.6.4. Business Units

11.6.5. Developments

11.6.6. Business Strategy

11.7. ERT CLINICAL

11.7.1. Overview

11.7.2. Product Offerings

11.7.3. Geographic Revenue

11.7.4. Business Units

11.7.5. Developments

11.7.6. Business Strategy

11.8. Merge Healthcare Incorporated

11.8.1. Overview

11.8.2. Product Offerings

11.8.3. Geographic Revenue

11.8.4. Business Units

11.8.5. Developments

11.8.6. Business Strategy

11.9. Omnicomm Systems, Incs.

11.9.1. Overview

11.9.2. Product Offerings

11.9.3. Geographic Revenue

11.9.4. Business Units

11.9.5. Developments

11.9.6. Business Strategy

11.10. Maxisit Inc

11.10.1. Overview

11.10.2. Product Offerings

11.10.3. Geographic Revenue

11.10.4. Business Units

11.10.5. Developments

11.10.6. Business Strategy

12. Companies to Watch

12.1. Aris Global

12.1.1. Overview

12.1.2. Market

12.1.3. Business Strategy

12.2. Advarra

12.2.1. Overview

12.2.2. Market

12.2.3. Business Strategy

12.3. Eclinicalworks

12.3.1. Overview

12.3.2. Market

12.3.3. Business Strategy

12.4. Mastercontrol, Inc.

12.4.1. Overview

12.4.2. Market

12.4.3. Business Strategy

12.5. Resonance Health

12.5.1. Overview

12.5.2. Market

12.5.3. Business Strategy

13. Analyst Opinion

14. Annexure

14.1. Report Scope

14.2. Market Definitions

14.3. Research Methodology

14.3.1. Data Collation and In-house Estimation

14.3.2. Market Triangulation

14.3.3. Forecasting

14.4. Report Assumptions

14.5. Declarations

14.6. Stakeholders

14.7. Abbreviations

TABLE 1.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 2.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 3.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR CLINICAL TRIAL MANAGEMENT SYSTEMS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR CLINICAL ANALYTICS PLATFORM, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 5.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR ELECTRONIC TRAIL MASTER FILES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 8.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR SAFETY SOLUTION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR ELECTRONIC TRAIL MASTER FILES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR REGULATORY INFORMATION MANAGEMENT SOLUTIONS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 12.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 13.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR WEB-HOSTED, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 14.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR LICENSED ENTERPRISE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR CLOUD-BASED, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR END USER, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17.    GLOBAL ECLINICAL SOLUTIONSMARKET VALUE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 18.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR CONTRACT RESEARCH ORGANIZATIONS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR CONSULTING SERVICE COMPANIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 20.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR MEDICAL DEVICE MANUFACTURERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 21.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 22.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR ACADEMIC RESEARCH INSTITUTIONS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 23.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR CLINICAL TRIAL PHASE, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 24.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR PHASE I, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 25.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR PHASE II, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 26.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR PHASE III, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 27.    GLOBAL ECLINICAL SOLUTIONS MARKET VALUE FOR PHASE IV, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 28.    NORTH AMERICA ECLINICAL SOLUTIONSMARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 29.    NORTH AMERICA ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 30.    NORTH AMERICA ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 31.    NORTH AMERICA ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 32.    U.S ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 33.    U.S ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 34.    U.S ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 35.    CANADA ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 36.    CANADA ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 37.    CANADA ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 38.    EUROPE ECLINICAL SOLUTIONSMARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 39.    EUROPE ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 40.    EUROPE ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 41.    EUROPE ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 42.    ASIA PACIFIC ECLINICAL SOLUTIONSMARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 43.    ASIA PACIFIC ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 44.    ASIA PACIFIC ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 45.    ASIA PACIFIC ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 46.    REST OF WORLD ECLINICAL SOLUTIONSMARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 47.    REST OF WORLD ECLINICAL SOLUTIONSMARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48.    REST OF WORLD ECLINICAL SOLUTIONSMARKET VALUE, BY DELIVERY MODE, 2020-2026 (USD MILLION)
TABLE 49.    REST OF WORLD ECLINICAL SOLUTIONSMARKET VALUE, BY CLINICAL TRIAL PHASE, 2020-2026 (USD MILLION)
TABLE 50.    ORACLE CORPORATION.: OVERVIEW    
TABLE 51.    ORACLE CORPORATION.: STRATEGIC SNAPSHOT    
TABLE 52.    ORACLE CORPORATION.: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 53.    ORACLE CORPORATION.:  PRODUCT/SERVICE PORTFOLIO
TABLE 54.    MEDIDATA SOLUTIONS, INC: OVERVIEW    
TABLE 55.    MEDIDATA SOLUTIONS, INC: STRATEGIC SNAPSHOT    
TABLE 56.    MEDIDATA SOLUTIONS, INC: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 57.    MEDIDATA SOLUTIONS, INC:  PRODUCT/SERVICE PORTFOLIO
TABLE 58.    PAREXEL INTERNATIONAL CORPORATION: OVERVIEW    
TABLE 59.    PAREXEL INTERNATIONAL CORPORATION: STRATEGIC SNAPSHOT    
TABLE 60.    PAREXEL INTERNATIONAL CORPORATION: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 61.    PAREXEL INTERNATIONAL CORPORATION:  PRODUCT/SERVICE PORTFOLIO
TABLE 62.    BIOCLINICA, INC.: OVERVIEW    
TABLE 63.    BIOCLINICA, INC.: STRATEGIC SNAPSHOT    
TABLE 64.    BIOCLINICA, INC.: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 65.    BIOCLINICA, INC.:  PRODUCT/SERVICE PORTFOLIO
TABLE 66.    THERMO FISHER SCIENTIFIC, INC: OVERVIEW    
TABLE 67.    THERMO FISHER SCIENTIFIC, INC: STRATEGIC SNAPSHOT    
TABLE 68.    THERMO FISHER SCIENTIFIC, INC: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 69.    THERMO FISHER SCIENTIFIC, INC:  PRODUCT/SERVICE PORTFOLIO
TABLE 70.    Crf Health.: OVERVIEW    
TABLE 71.    Crf Health.: STRATEGIC SNAPSHOT    
TABLE 72.    Crf Health.: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 73.    Crf Health.:  PRODUCT/SERVICE PORTFOLIO
TABLE 74.    ERT CLINICAL: OVERVIEW    
TABLE 75.    ERT CLINICAL: STRATEGIC SNAPSHOT    
TABLE 76.    ERT CLINICAL: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 77.    ERT CLINICAL:  PRODUCT/SERVICE PORTFOLIO
TABLE 78.    MERGE HEALTHCARE INCORPORATED.: OVERVIEW    
TABLE 79.    MERGE HEALTHCARE INCORPORATED.: STRATEGIC SNAPSHOT    
TABLE 80.    MERGE HEALTHCARE INCORPORATED.: BUSINESS OPPORTUNITIES AND OUTLOOK
TABLE 81.    MERGE HEALTHCARE INCORPORATED.:  PRODUCT/SERVICE PORTFOLIO
TABLE 82.    OMNICOMM SYSTEMS, INCS.: OVERVIEW    
TABLE 83.    OMNICOMM SYSTEMS, INCS.: STRATEGIC SNAPSHOT    
TABLE 84.    OMNICOMM SYSTEMS, INCS.: BUSINESS OPPORTUNITIES AND OUTLOOK    
TABLE 85.    OMNICOMM SYSTEMS, INCS.:  PRODUCT/SERVICE PORTFOLIO
TABLE 86.    MAXISIT INC.: OVERVIEW    
TABLE 87.    MAXISIT INC.: STRATEGIC SNAPSHOT    
TABLE 88.    MAXISIT INC.: BUSINESS OPPORTUNITIES AND OUTLO    
TABLE 89.    MAXISIT INC.:  PRODUCT/SERVICE PORTFOLIO

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$4500
This license allows multiple user to access the PDF.

Electronic (PDF)
$5500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Secure Hospital Communications Market Insights Forecast to 2028
Global Secure Hospital Communications Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-4H6366
Wed Nov 09 00:00:00 UTC 2022

Add to Cart

Global Urgent Care Center Market Insights Forecast to 2028
Global Urgent Care Center Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-38N5947
Wed Nov 09 00:00:00 UTC 2022

Add to Cart

Global Ambulatory Surgery Centre Market Insights Forecast to 2028
Global Ambulatory Surgery Centre Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-4H6311
Tue Nov 08 00:00:00 UTC 2022

Add to Cart

Global Mobile Hospitals Market Insights and Forecast to 2028
Global Mobile Hospitals Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-13F9304
Tue Oct 11 00:00:00 UTC 2022

Add to Cart